US3097139A
(en)
*
|
1960-03-10 |
1963-07-09 |
Ici Ltd |
Hypocholesterolaemia compositions
|
BE630211A
(de)
*
|
1962-03-28 |
|
|
|
GB992152A
(en)
*
|
1962-07-11 |
1965-05-19 |
Prodotti Schering Soc It |
Aminoesters
|
US3332842A
(en)
*
|
1963-08-30 |
1967-07-25 |
Ciba Geigy Corp |
Ether acids and derivatives thereof
|
US3332957A
(en)
*
|
1964-09-02 |
1967-07-25 |
Ciba Geigy Corp |
Amino esters of substituted phenoxy acetic acids
|
BE674556A
(de)
*
|
1965-01-05 |
1966-06-30 |
|
|
US3452081A
(en)
*
|
1965-05-27 |
1969-06-24 |
Merck & Co Inc |
Phenoxy substituted 2-alkenoic acids
|
GB1121722A
(en)
*
|
1966-03-31 |
1968-07-31 |
Ici Ltd |
New carboxylic acid derivatives
|
US3538227A
(en)
*
|
1967-01-30 |
1970-11-03 |
Ciba Geigy Corp |
Tricyclic phenoxy-acid and ester hypocholesterolemic compositions
|
SE344742B
(de)
*
|
1968-09-25 |
1972-05-02 |
Ciba Geigy Ag |
|
US4031134A
(en)
*
|
1969-04-16 |
1977-06-21 |
Sumitomo Chemical Company, Limited |
Phenoxy carboxylic acid derivative
|
US3716583A
(en)
*
|
1969-04-16 |
1973-02-13 |
Sumitomo Chemical Co |
Phenoxy carboxylic acid derivative
|
FR2043488A1
(de)
*
|
1969-05-29 |
1971-02-19 |
Roussel Uclaf |
|
US3692895A
(en)
*
|
1970-09-08 |
1972-09-19 |
Norman A Nelson |
Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
|
GB1348642A
(en)
*
|
1970-10-15 |
1974-03-20 |
Howard A N |
Hypocholesterolaemic compositions
|
FR2108980A1
(en)
*
|
1970-10-27 |
1972-05-26 |
Biosedra Lab |
Pure ethyl alpha-p-iodophenoxyisobutyrate - with hypolipaemic activity
|
FR2126077A1
(en)
*
|
1971-02-23 |
1972-10-06 |
Lafon Victor |
Ethyl (3, 5-diethoxy-phenoxy)isobutyrate - as hypocholesteremic
|
JPS575214B2
(de)
*
|
1972-06-01 |
1982-01-29 |
|
|
US3952096A
(en)
*
|
1973-06-15 |
1976-04-20 |
Bristol-Myers Company |
Mixture of calcium carbonate and calcium-α-p-chlorophenoxyisobutyrate as an antihyperlipemic agent
|
DE2342118C2
(de)
*
|
1973-08-21 |
1982-09-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Phenoxypropionsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
|
US4039683A
(en)
*
|
1973-08-21 |
1977-08-02 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Phenoxypropionic acid derivatives and pharmaceutical preparations containing same
|
CH617417A5
(de)
*
|
1973-12-27 |
1980-05-30 |
Siegfried Ag |
|
NL7416412A
(nl)
*
|
1973-12-27 |
1975-07-01 |
Siegfried Ag |
Werkwijze ter bereiding van nieuwe cholesterol- gende verbindingen.
|
AT353776B
(de)
*
|
1973-12-27 |
1979-12-10 |
Siegfried Ag |
Verfahren zur herstellung von neuen alkan- saeuren, deren estern und salzen
|
US4182902A
(en)
*
|
1973-12-27 |
1980-01-08 |
Siegfried Aktiengesellschaft |
Novel cholesterol-lowering compounds
|
US4012523A
(en)
*
|
1974-01-24 |
1977-03-15 |
The Dow Chemical Company |
Hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-(thio or sulfonyl) alkanoic acids and derivatives
|
US4067998A
(en)
*
|
1974-02-11 |
1978-01-10 |
The Dow Chemical Company |
2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
|
DK115374A
(de)
|
1974-03-04 |
1975-11-03 |
Byk Gulden Lomberg Chem Fab |
|
US4243819A
(en)
*
|
1978-02-16 |
1981-01-06 |
Zoecon Corporation |
Substituted amino acids
|
US4250191A
(en)
*
|
1978-11-30 |
1981-02-10 |
Edwards K David |
Preventing renal failure
|
JPS58150563A
(ja)
*
|
1982-03-04 |
1983-09-07 |
Taisho Pharmaceut Co Ltd |
3−ベンゾイル−2−メルカプトプロピオン酸誘導体
|
US4704402A
(en)
*
|
1982-06-12 |
1987-11-03 |
University Of Pittsburgh |
Method of treating sickle cell anemia
|
US4482571A
(en)
*
|
1982-06-21 |
1984-11-13 |
University Of Pittsburgh |
Sickle cell anemia treatment and compound
|
IN160141B
(de)
*
|
1983-05-09 |
1987-06-27 |
Council Scient Ind Res |
|
DK305884A
(da)
*
|
1983-06-24 |
1984-12-25 |
Yamanouchi Pharma Co Ltd |
Phenoxyderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
|
EP0320501A3
(de)
*
|
1983-06-24 |
1989-12-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Phenoxyderivate, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
|
DE3621861A1
(de)
*
|
1986-06-30 |
1988-01-14 |
Laszlo Dr Med Ilg |
Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
|
US4859703A
(en)
*
|
1987-06-15 |
1989-08-22 |
Warner-Lambert Company |
Lipid regulating compositions
|
EP0515684A4
(en)
*
|
1990-02-14 |
1993-04-21 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibitor of denatured ldl formation
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6083497A
(en)
|
1997-11-05 |
2000-07-04 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
|
ATE234084T1
(de)
*
|
1998-06-02 |
2003-03-15 |
Arthromics Plc |
Substanzen, die mit dem thyroid-hormonrezeptor interagieren, zur behandlung fibrotischer erkrankungen
|
EA004231B1
(ru)
*
|
1998-12-23 |
2004-02-26 |
Джи.Ди.Сирл Ллс |
Сочетание ингибиторов белка, переносящего эфир холестерила, и производных фибриновой кислоты для сердечно-сосудистых показаний
|
EP1140189B1
(de)
*
|
1998-12-23 |
2003-05-14 |
G.D. Searle LLC. |
Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
|
ATE242008T1
(de)
|
1998-12-23 |
2003-06-15 |
Searle Llc |
Kombnationen von cholesteryl ester transfer protein inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen
|
ES2201822T3
(es)
|
1998-12-23 |
2004-03-16 |
G.D. Searle Llc |
Combinaciones de inhibididores de la proteina de transferencia de ester de colesterilo y de derivados de acido nicotinico para indicaciones cardiovasculares.
|
NZ512532A
(en)
*
|
1998-12-23 |
2003-12-19 |
G |
Combinations for treating cardiovascular diseases like hypercholesterolemia and atherosclerosis
|
AU2157400A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
|
ATE228012T1
(de)
*
|
1998-12-23 |
2002-12-15 |
Searle Llc |
Kombinationen von ileumgallensäuretransports inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen
|
EP1140188B1
(de)
*
|
1998-12-23 |
2003-05-28 |
G.D. Searle LLC. |
Kombinationen von ileumgallensäuretransports inhibitoren und cholesteryl ester transfer protein inhibitoren
|
JP2003528830A
(ja)
|
2000-03-10 |
2003-09-30 |
ファルマシア・コーポレーション |
テトラヒドロベンゾチエピン類の製造方法
|
WO2001068096A2
(en)
*
|
2000-03-10 |
2001-09-20 |
Pharmacia Corporation |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
US20040077625A1
(en)
*
|
2001-07-25 |
2004-04-22 |
Tremont Samuel J. |
Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
|
BR0213501A
(pt)
*
|
2001-11-02 |
2004-08-24 |
Searle Llc |
Compostos de benzotiepina mono- e di-fluorada como inibidores de transporte de ácido biliar co-dependente de sódio apical (asbt) e captação de taurocolato
|
MXPA04006255A
(es)
|
2002-01-17 |
2004-09-27 |
Pharmacia Corp |
Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
|
ITRM20020629A1
(it)
*
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
WO2004108126A1
(en)
*
|
2003-06-06 |
2004-12-16 |
Snowden Pharmaceuticals, Llc |
Fibric acid derivatives for the treatment of irritable bowel syndrome
|
US7390504B2
(en)
*
|
2003-11-07 |
2008-06-24 |
Jj Pharma, Inc. |
HDL-boosting combination therapy complexes
|
US20070190079A1
(en)
*
|
2004-10-29 |
2007-08-16 |
Kalypsys, Inc. |
Methods for the selective modulation of ppar
|
FR2880887B1
(fr)
*
|
2005-01-14 |
2009-01-30 |
Merck Sante Soc Par Actions Si |
Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
US20100210633A1
(en)
*
|
2006-10-12 |
2010-08-19 |
Epix Delaware, Inc. |
Carboxamide compounds and their use
|
CL2008000684A1
(es)
|
2007-03-09 |
2008-08-01 |
Indigene Pharmaceuticals Inc |
Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
|
WO2008157537A2
(en)
*
|
2007-06-19 |
2008-12-24 |
Ironwood Pharmaceuticals, Inc |
Compositions and methods of use for treating or preventing lipid related disorders
|
WO2009076404A1
(en)
*
|
2007-12-10 |
2009-06-18 |
Epix Delaware, Inc. |
Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
|
AU2008335135A1
(en)
|
2007-12-11 |
2009-06-18 |
Cytopathfinder, Inc. |
Carboxamide compounds and their use as chemokine receptor agonists
|
CN106518769A
(zh)
|
2009-08-03 |
2017-03-22 |
方济各安吉利克化学联合股份有限公司 |
1‑苄基‑3‑羟甲基‑1h‑吲唑及其衍生物以及所需镁中间体的制备方法
|
PE20180027A1
(es)
|
2015-02-06 |
2018-01-09 |
Intercept Pharmaceuticals Inc |
Composiciones farmaceuticas para terapia combinada
|
KR101956805B1
(ko)
*
|
2019-02-21 |
2019-03-11 |
한국식품연구원 |
부테인 또는 이소유제놀을 포함하는 pcsk9 유전자의 발현 감소 또는 저밀도 지단백 수용체 증가용 조성물
|